Technology | Artificial Intelligence | December 05, 2018

GE Healthcare Unveils New Applications and Smart Devices Built on Edison Platform

Artificial intelligence platform combines globally diverse data sets from across modalities, vendors, healthcare networks and life sciences settings

GE Healthcare Unveils New Applications and Smart Devices Built on Edison Platform

December 5, 2018 — GE Healthcare recently announced new applications and smart devices built on Edison – a platform that helps accelerate the development and adoption of artificial intelligence (AI) technology and empower providers to deliver faster, more precise care. Edison is part of GE Healthcare’s $1 billion and growing Digital portfolio and will serve as a “digital thread” for its existing AI partnerships and products. Clinical partners will use Edison to develop algorithms, and technology partners will work with GE Healthcare to bring the latest advancements in data processing to Edison applications and smart devices.

The healthcare AI market will reach $6.6 billion in 2021, and 39 percent of healthcare provider executives say that they’re investing in AI, machine learning and predictive analytics, according to GE. Appreciating the technology’s potential, GE Healthcare presented the following Edison applications and Edison-powered devices at the 104th annual meeting of the Radiological Society of North America (RSNA), Nov. 25-30 in Chicago.

  • AIRx is an AI-based, automated workflow tool for magnetic resonance imaging (MRI) brain scanning designed to increase consistency and productivity. AIRx is designed to provide automated slice prescriptions to help reduce previously redundant, manual steps. AIRx is intended to produce images that have less variability between technologists and between scans, to help lower the chances for a patient to be recalled due to incorrect slice placement. An increase in consistency is particularly important when doing longitudinal assessments for diseases like Alzheimer’s and multiple sclerosis. AIRx features a pre-trained neural network model that leverages deep learning algorithms and anatomy recognition based on a database of over 36,000 images sourced from clinical studies and reference sites. The application is U.S. Food and Drug Administration (FDA) 510(k) pending and is not available for sale.
  • Critical Care Suite on the Optima XR240amx digital radiography (DR) system is designed to identify cases with the critical condition of pneumothorax at the point-of-care to enable prioritization of image review. Critical Care Suite will employ a suite of AI algorithms, such as pneumothorax detection, designed to identify this potentially life- threatening condition in chest X-rays with high accuracy (>0.95 AUC). The AI algorithms are hosted on the mobile X-ray system – a first of its kind AI-embedded imaging device, according to GE – designed to share the output through an onscreen notification. When a pneumothorax condition is identified, the point-of-care notification alerts the clinical team, enabling prioritization of image review. The AI results are sent to the picture archiving and communication system (PACS) for review of the critical findings by a radiologist. The application is U.S. Food and Drug Administration (FDA) 510(k) pending and is not available for sale.  
  • CT Smart Subscription provides continuous access to the latest computed tomography (CT) software, extending the lifecycle of the device and making it more valuable over time. Applications can be selected based on a hospital or health system’s unique needs, with options ranging from intracranial hemorrhage and stroke detection to routine dose reduction and optimization to cardiac function assessment.
  • Automated Lesion Segmentation on Logiq E10 increases productivity through automation. Ultrasound users experience significant ergonomic challenges due to repetitive exam steps. Automated Lesion Segmentation helps eliminate the need for the user to measure lesions manually, by segmenting an identified breast, thyroid or liver lesion and automatically providing a trace of the lesion and corresponding area. This feature also helps ensure consistency among different users, or even the same user, for documentation and follow-ups.

“There's a lot of hidden meaning in the deep data, but it takes a significant sophistication to extract the value,” said Rachael Callcut, M.D., a partner in the development of Critical Care Suite, associate professor of surgery at UCSF, a surgeon at UCSF Health and director of data science for the Center for Digital Health Innovation. “AI gives us an opportunity to see patterns that we don't see and change the way we care for patients, which can ultimately improve outcomes.”

Edison also offers a service that allows data to be traced during the development of an algorithm. This tool could boost clinicians’ trust in the technology and simplify a developer’s ability to create compliant AI applications. The AI capabilities are just one of the more than 100 Edison services available to GE Healthcare and ultimately third-party developers. Other services include security, visualization, utilization management and auto-protocoling.

For hospital executives, the Edison platform allows GE Healthcare to add continuous value to its millions of installed medical devices with smart workflows. Clinicians who use Edison applications, which were built using Edison services, can be assured that algorithms were developed with and validated by an ecosystem of clinical and technology partners. Developers who use Edison will benefit from a common integrated platform that brings together globally diverse data from across modalities, vendors and care settings.

Edison applications can be deployed on medical devices, via the cloud or on the edge (computing technology that sits close to the physical device).

For more information: www.gehealthcare.com

 

Related Content

FDA Approves New Features for Planmed Verity Cone Beam CT Scanner
Technology | Computed Tomography (CT) | December 07, 2018
The U.S. Food and Drug Administration (FDA) issued an approval letter for the new features and intended uses of the...
Youth Football Changes Nerve Fibers in Brain

Statistically significant clusters (red-colored) showing group differences (Control vs. Football) in white matter strain along the primary (F1) and secondary (F2) fibers. While body of corpus callosum (BBC) showed relative shrinkage in Football group, the other clusters showed relative stretching of fibers. PCR: Posterior Corona Radiata, PLIC: Posterior Limb of Internal Capsule, SCR: Superior Corona Radiata, SLF: Superior Longitudinal Fasciculus, SCC: Splenium of Corpus Callosum. Image courtesy of Kim et al.

News | Neuro Imaging | December 07, 2018
Magnetic resonance imaging (MRI) scans show repetitive blows to the head result in brain changes among youth football...
Hitachi Medical Systems Europe Introduces Third-Generation Intelligent Vector Flow Mapping
News | Cardiovascular Ultrasound | December 07, 2018
Hitachi Medical Systems Europe introduced what it calls the next level of intelligent Vector Flow Mapping (iVFM) at...
FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...
USEI Introduces Window-based iPad Medical Imaging Viewing Solution at RSNA 2018
Technology | Flat Panel Displays | December 06, 2018
U.S. Electronics Inc. (USEI) recently announced the release of what it calls the world’s first Windows-compatible...
YITU Releases AI-Based Cancer Screening Solutions at RSNA 2018
News | Artificial Intelligence | December 06, 2018
Chinese artificial intelligence (AI) healthcare company YITU healthcare released two brand-new products, Intelligent...
Spectrum Dynamics Sues GE for Theft, Misappropriation of Trade Secrets and Unfair Competition
News | SPECT Imaging | December 06, 2018
Single-photon emission computed tomography (SPECT) cardiac imaging company Spectrum Dynamics filed a lawsuit Dec. 6,...
Siemens Healthineers Debuts Magnetom Altea 1.5T MRI Scanner
Technology | Magnetic Resonance Imaging (MRI) | December 06, 2018
During the 104th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Nov. 25-30...
Guerbet Launches Multi-Use OptiVantage Contrast Media Injector in Europe
Technology | Contrast Media Injectors | December 05, 2018
Contrast agent company Guerbet recently announced that the OptiVantage multi-use contrast media injector is now CE...